158 related articles for article (PubMed ID: 32222118)
1. Knockdown of HIF1A-AS2 suppresses TRIM44 to protect cardiomyocytes against hypoxia-induced injury.
Luo F; Wu Y; Zhu L; Zhang J; Liu Y; Jia W
Cell Biol Int; 2020 Jul; 44(7):1523-1534. PubMed ID: 32222118
[TBL] [Abstract][Full Text] [Related]
2. lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1α by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia.
Li L; Wang M; Mei Z; Cao W; Yang Y; Wang Y; Wen A
Biomed Pharmacother; 2017 Dec; 96():165-172. PubMed ID: 28985553
[TBL] [Abstract][Full Text] [Related]
3. The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer.
Chen X; Liu M; Meng F; Sun B; Jin X; Jia C
J Cell Biochem; 2019 Jan; 120(1):243-252. PubMed ID: 30216500
[TBL] [Abstract][Full Text] [Related]
4. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HIF1A-AS2 mediates imatinib resistance by regulating autophagy in gastrointestinal stromal tumor cells.
Yan J; Chen X; Lin J; Sun X; Chen W
Neoplasma; 2023 Aug; 70(4):526-533. PubMed ID: 37789783
[TBL] [Abstract][Full Text] [Related]
6. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.
Chen WM; Huang MD; Kong R; Xu TP; Zhang EB; Xia R; Sun M; De W; Shu YQ
Dig Dis Sci; 2015 Jun; 60(6):1655-62. PubMed ID: 25686741
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA HIF1A-AS2 facilitates cell survival and migration by sponging miR-33b-5p to modulate SIRT6 expression in osteosarcoma.
Lin H; Zhao Z; Hao Y; He J; He J
Biochem Cell Biol; 2020 Apr; 98(2):284-292. PubMed ID: 31626739
[TBL] [Abstract][Full Text] [Related]
8. LncRNA HIF1A-AS2: a potential biomarker for early diagnosis of acute myocardial infarction and predictor of left ventricular dysfunction.
Tayae E; Amr E; Zaki A; Elkaffash D
BMC Cardiovasc Disord; 2023 Mar; 23(1):135. PubMed ID: 36918770
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA HIF1A-AS2 promotes carcinogenesis by enhancing Gli1-mediated HIF1α expression in clear cell renal cell carcinoma.
Li X; Wu Y; Xiao Z; Liu Y; Wang C; Zhou L; Yang X
Pathol Res Pract; 2024 Jan; 253():154984. PubMed ID: 38064865
[TBL] [Abstract][Full Text] [Related]
10. [Silencing long non-coding RNA HIF1A-AS2 inhibits proliferation, invasion and migration of cervical cancer cells
Deng R; Zhang F; Lei F; Liu W; Liu S; Wang W
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1615-1621. PubMed ID: 33243752
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HIF1A-AS2 promotes osteosarcoma progression by acting as a sponge of miR-129-5p.
Wang X; Peng L; Gong X; Zhang X; Sun R
Aging (Albany NY); 2019 Dec; 11(24):11803-11813. PubMed ID: 31866584
[TBL] [Abstract][Full Text] [Related]
12. Asiatic acid enhances survival of human AC16 cardiomyocytes under hypoxia by upregulating miR-1290.
Wu K; Hu M; Chen Z; Xiang F; Chen G; Yan W; Peng Q; Chen X
IUBMB Life; 2017 Sep; 69(9):660-667. PubMed ID: 28686797
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer.
Yang K; Zhang W; Zhong L; Xiao Y; Sahoo S; Fassan M; Zeng K; Magee P; Garofalo M; Shi L
Cell Death Differ; 2023 Jun; 30(6):1533-1549. PubMed ID: 37041291
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA HIF1A-AS2 modulates the proliferation, migration, and phenotypic switch of aortic smooth muscle cells in aortic dissection via sponging microRNA-33b.
Zhang K; Qi Y; Wang M; Chen Q
Bioengineered; 2022 Mar; 13(3):6383-6395. PubMed ID: 35212609
[TBL] [Abstract][Full Text] [Related]
15. ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644/TRIM44 axis.
Lei R; Feng L; Hong D
Cancer Biomark; 2020; 27(4):433-443. PubMed ID: 31929141
[TBL] [Abstract][Full Text] [Related]
16. The inhibitive effect of sh-HIF1A-AS2 on the proliferation, invasion, and pathological damage of breast cancer via targeting miR-548c-3p through regulating HIF-1α/VEGF pathway in vitro and vivo.
Guo X; Lee S; Cao P
Onco Targets Ther; 2019; 12():825-834. PubMed ID: 30774370
[TBL] [Abstract][Full Text] [Related]
17. HIF1A-AS2 predicts poor prognosis and regulates cell migration and invasion in triple-negative breast cancer.
Wang Y; Zhang G; Han J
J Cell Biochem; 2019 Jun; 120(6):10513-10518. PubMed ID: 30635931
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HIF1A-AS2 positively affects the progression and EMT formation of colorectal cancer through regulating miR-129-5p and DNMT3A.
Lin J; Shi Z; Yu Z; He Z
Biomed Pharmacother; 2018 Feb; 98():433-439. PubMed ID: 29278853
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy.
Güçlü E; Eroğlu Güneş C; Kurar E; Vural H
Med Oncol; 2021 Aug; 38(9):113. PubMed ID: 34378101
[TBL] [Abstract][Full Text] [Related]
20. Inducible miR-145 expression by HIF-1a protects cardiomyocytes against apoptosis via regulating SGK1 in simulated myocardial infarction hypoxic microenvironment.
Sun N; Meng F; Xue N; Pang G; Wang Q; Ma H
Cardiol J; 2018; 25(2):268-278. PubMed ID: 28980287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]